这里是 junpeilong 的丁香客，立即开通并关注，最新动态不容错过！马上登录加入丁香客
Leflunomide improves psoriasis in patients with psoriatic arthritis: an in-depth analysis of data from the TOPAS study.
Leflunomide for the successful management of juvenile Cogan\'s syndrome.
Leflunomide and methotrexate combination in refractory adult-onset Still\'s disease.
Treatment of adult-onset Still\'s disease with leflunomide and chloroquine combination in two patients.
Leflunomide in psoriatic polyarthritis.
Open trial of leflunomide for refractory psoriasis and psoriatic arthritis.
Transition from endocapillary proliferative glomerulonephritis to membranoproliferative glomerulonephritis in a patient with a prolonged human parvovirus B19 infection.
BK Polyomavirus in Solid Organ Transplantation.
Efficacy and tolerability of leflunomide in difficult-to-treat polymyalgia rheumatica and giant cell arteritis: a case series.
Efficacy and safety of leflunomide in treatment of steroid-dependent and steroid-resistant adult onset minimal change disease.
The SMILE Study -- Safety of Methotrexate in Combination with Leflunomide in Rheumatoid Arthritis.
Leflunomide in dialysis patients with rheumatoid arthritis-a pharmacokinetic study.
Leflunomide therapy for BK virus allograft nephropathy after pediatric kidney transplantation.
Efficacy and safety of leflunomide in DMARD-naive patients with early rheumatoid arthritis: comparison of a loading and a fixed-dose regimen.
Combination of MTX and LEF attenuates inflammatory bone erosion by down-regulation of receptor activator of NF-kB ligand and interleukin-17 in type II collagen-induced arthritis rats.
Control of apoptosis in human multiple myeloma by insulin-like growth factor I (IGF-I).
Protein kinase inhibitors can control the progression of endometriosis in vitro and in vivo.
The immunomodulatory drug Leflunomide inhibits cell cycle progression of B-CLL cells.
The immunosuppressive metabolite of leflunomide, A77 1726, affects murine T cells through two biochemical mechanisms.
Role of NF-kappaB and Akt/PI3K in the resistance of pancreatic carcinoma cell lines against gemcitabine-induced cell death.